Showing results (371-380 of 379) with videos related to

Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 379 results.
Oncogene|December 18, 2020
Cigarette smoke-induced LKB1/AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLCFang-Ju Cheng, Chia-Hung Chen, Wen-Chen Tsai, et al.
The Lancet. Oncology|April 20, 2023
Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trialLinda R Mileshkin, Kathleen N Moore, Elizabeth H Barnes, et al.
The Lancet. Oncology|August 5, 2024
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trialNicoletta Colombo, Elena Biagioli, Kenichi Harano, et al.
The Journal of Biological Chemistry|February 1, 2022
Tafenoquine and its derivatives as inhibitors for the severe acute respiratory syndrome coronavirus 2Yeh Chen, Wen-Hao Yang, Hsiao-Fan Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 3, 2026
CD3ɛ Nanobody-Engineered Extracellular Vesicles Driving In Vivo Generation of BiTE-Secreting CAR-Ts for Solid Tumor Therapy With Memory Response and Minimal ImmunogenicityShi-Wei Huang, Yu-Chuan Lin, Chih-Ming Pan, et al.
Nature Communications|November 5, 2025
Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trialChee Khoon Lee, Apriliana E R Kartikasari, Nirashaa T Bound, et al.
The American Journal of Surgical Pathology|October 28, 2024
International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms: Outcome of Primary Localized DiseaseClaudia Giani, Abdulazeez Salawu, Silva Ljevar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2022
TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family MembersRachel Delahunty, Linh Nguyen, Stuart Craig, et al.
JAMA Oncology|June 25, 2026
Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP InhibitorsLucy Haggstrom, Yeh Chen Lee, Maria-Pilar Barretina-Ginesta, et al.
Pageof 38